# Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA

> **NCT02730728** · NA · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 159 (actual)

## Conditions studied

- Total Knee Arthroplasty
- Osteoarthritis
- Post Operative Pain Control

## Interventions

- **DRUG:** 20ml bolus of 0.5% ropivicaine
- **DRUG:** 0.2% Ropivicaine at 8 milliliter/hour
- **DRUG:** 5ml bolus of 0.5% ropivicaine

## Key facts

- **NCT ID:** NCT02730728
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2016-06-30
- **Final completion:** 2017-01-01
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2018-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02730728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02730728, "Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02730728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*